Great Lakes NeuroTechnologies Receives UKCA Mark for KinesiaU™ Motor Assessment System

Transparenz: Redaktionell erstellt und geprüft.
Veröffentlicht am

Great Lakes NeuroTechnologies (GLNT) is proud to announce that its KinesiaU™ motor assessment system has received the UKCA mark and will now be available in the United Kingdom in addition to the United States. KinesiaU allows patients with movement disorders such as Parkinson's disease to track their tremor, slowness and dyskinesia in response to therapy with an app on their personal smartwatch and smartphone. Patients see their symptoms in easy-to-use reports on their smartphones, and doctors access their patients' data in real time through the KinesiaU provider portal to make better treatment decisions and recommend therapies and activities to improve symptoms...

Great Lakes NeuroTechnologies (GLNT) ist stolz bekannt zu geben, dass sein Motorik-Bewertungssystem KinesiaU™ das UKCA-Zeichen erhalten hat und nun zusätzlich zu den Vereinigten Staaten auch in Großbritannien erhältlich sein wird. KinesiaU ermöglicht es Patienten mit Bewegungsstörungen wie der Parkinson-Krankheit, ihr Zittern, ihre Langsamkeit und ihre Dyskinesie als Reaktion auf die Therapie mit einer App auf ihrer persönlichen Smartwatch und ihrem Smartphone zu verfolgen. Patienten sehen ihre Symptome in benutzerfreundlichen Berichten auf ihren Smartphones und Ärzte greifen über das KinesiaU-Anbieterportal in Echtzeit auf die Daten ihrer Patienten zu, um bessere Behandlungsentscheidungen zu treffen und Therapien und Aktivitäten zur Verbesserung der Symptome …
Great Lakes NeuroTechnologies (GLNT) is proud to announce that its KinesiaU™ motor assessment system has received the UKCA mark and will now be available in the United Kingdom in addition to the United States. KinesiaU allows patients with movement disorders such as Parkinson's disease to track their tremor, slowness and dyskinesia in response to therapy with an app on their personal smartwatch and smartphone. Patients see their symptoms in easy-to-use reports on their smartphones, and doctors access their patients' data in real time through the KinesiaU provider portal to make better treatment decisions and recommend therapies and activities to improve symptoms...

Great Lakes NeuroTechnologies Receives UKCA Mark for KinesiaU™ Motor Assessment System

Great Lakes NeuroTechnologies (GLNT) is proud to announce that its KinesiaU™ motor assessment system has received the UKCA mark and will now be available in the United Kingdom in addition to the United States. KinesiaU allows patients with movement disorders such as Parkinson's disease to track their tremor, slowness and dyskinesia in response to therapy with an app on their personal smartwatch and smartphone. Patients see their symptoms in easy-to-use reports on their smartphones, and doctors access their patients' data in real time through the KinesiaU provider portal to make better treatment decisions and identify therapies and activities to improve their patients' symptoms.

We are delighted to receive the UKCA mark and make our KinesiaU product available to patients in the UK. This will enable the 150,000 people in the UK living with Parkinson’s disease to better monitor their symptoms and help their doctors manage their therapies.”

Dustin Heldman, Ph.D., President and COO, GLNT

Based on 15 years of development and validation of Great Lakes NeuroTechnologies' FDA-approved Kinesia™ technology, patented in the US and various European countries including the UK, KinesiaU is the only validated system for real-time remote monitoring of patients with Parkinson's disease with 24/7 clinical access to their patients' data. The KinesiaU Motor Assessment System is currently available in the UK after consultation with the patient's doctor and in the US by prescription.

Source:

Great Lakes NeuroTechnologies

.